ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 448

Citrulline-Specific Autoimmunity Resides in Quiescent Circulating Memory B Cells in Rheumatoid Arthritis

Adam Pelzek, Caroline Grönwall, Jeffrey D. Greenberg and Gregg J. Silverman, Medicine, New York University School of Medicine, New York, NY

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: ACPA, B cell memory, pathogenesis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose . The detection of anti-citrullinated protein antibodies (ACPA) aids RA diagnosis, while B cell depletion by anti-CD20 can provide clinical benefits. We therefore undertook investigations of the phenotypic and functional properties of citrulline (Cit)-specific B cells in the bloodstream of RA patients.  

Methods . RA met 2010 ACR/EULAR criteria. PBMC were cultured +/- CpG2006/IL-21/sCD40L, and ELISpots performed. CD19+ B cell subsets were FACS sorted and cultured with CD40L-cell line/CpG2006/IL-21.  Sera and supernatants were evaluated for total IgG, and for IgG1 and IgG4 subclasses by bead-based multiplex analysis, against 8 sets of paired Cit/native cyclic self-peptides, plus CCP3, CQP3 (Cit to Q), Cit/native fibrinogen (Fib), tetanus toxoid (TT) and control ligands. We also surveyed 87 CCP3-seropositive and 50 seronegative RA serum samples, plus panels of disease specific control samples (SS, OA, PsA, SLE).

Results . ELISpots documented the presence of circulating anti-Cit B cells, as seropositive RA had 41.3+/-0.5 CCP3+ IgG (mean +/-SE) but only 1.9+/-0.6 CQP+ spots/10(6) PBMC, while these were undetectable in seronegative RA and healthy adults.  Anti-TT ISC were detected at 71.1+/-2.6 and 65.4+/-1.2 spots/10(6)PBMC in seropositive RA and controls, respectively. By multiplex assay, ACPA fine specificity reactivities in sera were compared with supernatant antibodies from stimulated PBMC. In 36 PBMC from seropositive RA, highly significant correlations by ACPA fine specificity were found in comparisons with sera ACPA by Spearman correlations. From sorted B cells, we found ACPA-secreting B cells were enriched among CD19+IgD-CD27+ switched-memory (0.019 – 0.059% of CD19+CD27+IgD-), and included highly CCP3-reactive IgG.  Yet, only rare weakly CCP3-reactive naïve B cells (IgD+CD27-) were detected, and none amongst pre-switched memory (IgD+CD27+). From subclass-specific sera multiplex assays, amongst IgG1 ACPA-expressing seropositive RA, about half showed anti-CCP3 IgG1 only, while the remainder had both anti-CCP3 IgG1 and IgG4.  Whereas reactivity levels were generally greater for IgG1 than IgG4, IgG1 responses usually displayed great Cit than native antigen-specific responses, while the IgG4 displayed greater reactivity with the native (non-Cit) form in 5/9 antigen sets.

Conclusion . In seropositive RA PBMC, IgG ACPA in vitro secretion was detected across all treatment groups tested (MTX, MTX+TNFi, MTX+abatacept), suggesting these cells persist despite therapeutic intervention.  DAS28 score correlated with neither the level nor specificity of supernatant or sera ACPA. Pilot studies also suggest ACPA-secreting B cells predominantly reside within peripheral switched memory. Our data therefore suggest that seropositive RA patients have recirculating but quiescent memory B cells with repertoires akin to serum ACPA patterns. Furthermore, while IgG1 autoantibodies in RA are predominantly Cit-specific, with subclass switch to IgG4 there may be epitope spreading with progression to include recognition of determinants on the native forms of the self-antigens. Our studies highlight defects in B cell tolerance in RA that may help guide development of better therapy.


Disclosure:

A. Pelzek,
None;

C. Grönwall,
None;

J. D. Greenberg,
None;

G. J. Silverman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/citrulline-specific-autoimmunity-resides-in-quiescent-circulating-memory-b-cells-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology